VectorBuilder offers gene delivery solutions, including vector design, cloning, and manufacturing services. The company focuses on research and clinical applications.

VectorBuilder

VectorBuilder | 5,052 followers on LinkedIn. VectorBuilder is a global leader in gene delivery technologies.  | As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.

VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy.

Territory manager

Sandra Akpe San Roman, PhD

Sr. Scientific Manager & Visiting Research Fellow at the University of Sussex

Paola Dama

Head of Global Operations - Cell & Gene Therapy | Gene Editing | Biomanufacturing | Synthetic Biology

Alan Griffith Ph.D

Vectorbuilder VP of Strategies

黄锐Nicholas

We're proud to announce that our Chief Scientist, Dr. Bruce Lahn has been recognized on the 2024 Forbes China 100 Most Influential Chinese list. 🏆🎉 This distinguished annual selection honors 100 prominent Chinese figures shaping business, culture, and philanthropy globally, with past recipients including NVIDIA 's Jensen Huang . Dr. Lahn was chosen for his pivotal contributions to advancing life sciences worldwide. 🌍✨ In 2014, Dr. Lahn’s entrepreneurial drive led him to launch VectorBuilder, an online platform that has revolutionized gene delivery. 🧬 By automating and simplifying the design and ordering of gene delivery vectors, VectorBuilder has streamlined research for hundreds of thousands of life science labs around the world. The platform’s innovation and impact are reflected in over 5,000 scientific publications, and VectorBuilder’s client base spans more than 4,500 institutions in 90+ countries, including 90% of the top 100 QS-ranked universities and 90% of the top 30 global pharmaceutical companies. 🔗 Read more about Dr. Bruce Lahn's contributions and journey: https://lnkd.in/dTg3awjs

We're Going LIVE! 🔴 Join Our Webinar to Discover the Power of Mini Plasmids: https://lnkd.in/eBgnnbUF 💪 Today at 11:00 AM ET, discover how new mini plasmid technology is addressing safety concerns and improving gene therapy outcomes in our upcoming webinar, "Improving Gene Therapy Safety with Antibiotic- and Supplement-Free Mini Plasmids."

Last Chance! Join Our Webinar to Discover the Power of Mini Plasmids 💪 Register: https://lnkd.in/eBgnnbUF This Thursday, discover how new mini plasmid technology is addressing safety concerns and improving gene therapy outcomes in our upcoming webinar, "Improving Gene Therapy Safety with Antibiotic- and Supplement-Free Mini Plasmids." In this webinar, our experts—Application Scientist Cole Cheng, PhD, and Scientific Product Manager Connie Rich, PhD—will reveal how antibiotic- and supplement-free miniaturized plasmids are transforming therapeutic development. 📅 Save the Date: Thursday, November 14, 2024 🕒 Time: 11:00 AM - 12:30 PM ET 📍 Format: Live and On-Demand Access Available Don’t miss out on this chance to learn about a safer, more effective approach to gene therapy. Reserve your spot today: https://lnkd.in/eBgnnbUF

Meet VectorBuilder at the LION conference in Leipzig and use this established event at the IZI to share and discuss your latest experimental findings in Immune Oncology.

Nadine Müller, PhD

Upcoming Conferences 📢 Nov 15 - 18, 2024 | AHA with Senior Territory Manager Jessi Toumeh , Scientific Liaison Croydon Fernandes, Lead Application Scientist Charles Xingjian Bai , Scientific Product Manager Brady Strittmatter Nov 17 - 20, 2024 | The 4th Metabolic Diseases Meeting with Associate Director Thomas Leung Nov 18 - 20, 2024 | ISNN (11th international Symposium on Neuroprotection and Neurorepair) with Territory Manager Nadine Müller, PhD Join us in the gene delivery revolution: https://lnkd.in/g45YDh2p 🧬

Are you attending the ASSCR 2024 meeting? We are here at the National Wine Centre of Australia, South Australia. Please come to our booth to chat with us for more details about our gene delivery solutions for stem cell research! VectorBuilder VectorBee

Thomas Leung

Meet our Business Development Account Specialist Maria Pascual, PhD at the X Latin American Symposium on Cell Culture Technology, a conference that allows you to share and discuss results and experiences in animal cell culture applications. #SLATCC 📌From 13 to 16 November 2024 📍Hotel Marina del Rey, Viña del Mar 📲Register: https://shorturl.at/CIVsq 🤝Organized by: School of Biochemical Engineering of the Pontificia Universidad Católica de Valparaíso, together with researchers from the University of Chile and the University of Concepción.

We had a great time presenting at #ASHG ! You can still meet us at Booth #860 to learn more about our poster “Prevalence of errors in lab-made plasmids across the globe,” as well as VectorBuilder 's extensive list of products and services! ✨ Join us in the gene delivery revolution: www.VectorBuilder.com 🧬 #ASHG2024 #ASHG24 #HumanGenetics

Are you at #ASHG right now? Come meet us at booth #860 🧬 Have a chat with Scientific Liaison Croydon Fernandes, Territory Manager Richard Nemeth Ph.D. , and Account Manager Anil Poudel to learn how VectorBuilder can revolutionize all your gene delivery needs. We’re also presenting Poster Board #1087W - “Prevalence of errors in lab-made plasmids across the globe” from 🕝 2:30pm - 4:30pm MT… so don’t miss out! Join us in the gene delivery revolution: www.VectorBuilder.com #ASHG2024 #ASHG24 #HumanGenetics

Domain Not Resolving

SSL by Default

Google Tag Manager

HSTS

Google Analytics

DNSSEC

Content Delivery Network

Amazon

Font Awesome

Associate Sales Director - US

Rebecca Wright

Account Manager

Anil Poudel

Marketing and Product

Brady Strittmatter

Constance Rich

Office Manager

Grecia Perez

Program and Project Management

Joshua Zhang

Sales and Support

Justin Guay

Leandro Navarro

Maria Blasco

Sofia Parada

Bruce Lahn

Founder and Chief Scientific Officer

Great Lakes Companies With More Than 50 Employees (Top 10K)

Greater Chicago Area E-Commerce Companies

Great Lakes Companies With More Than 100 Employees (Top 10K)

Biotechnology Companies With Fewer Than 1000 Employees (Top 10K)

VectorBuilder is an online platform for vector cloning. The platform services such as gene delivery solution design, development, and optimization, scientific research vector customization, and clinical vector preparation. VectorBuilder offers a wide range of CRO services, including the application of many gene delivery technologies in basic scientific research and drug development, in addition to personalized vector and virus packaging.

Venture Round - VectorBuilder

Guangzhou Yuexiu Industrial Investment Fund

Series C - VectorBuilder

Legend Capital

Suikai Investment

Computer and Software Services and Scientific Services

Chicago

Illinois

United States

North America

VectorBuilder Founder and Chief Scientist, Dr. Bruce Lahn, Named to Forbes China Top 100 Oversea Chinese Elite

VectorBuilder Founder and Chief Scientist Dr. Bruce Lahn Named to Forbes China’s Top 100 Most Influential Chinese

Splicing neoantigen discovery with SNAF reveals shared ...

Efficient and reproducible generation of human induced ...

The IL-17-IL-17RA axis is required to promote osteosarcoma ...

Modeling phenotypic heterogeneity towards evolutionarily ...

Targeted delivery of a PD-1-blocking scFv by CD133-specific ...

China Digest: VectorBuilder joins unicorn club; Panlin Capital closes new RMB fund

New Unicorns In May Hit Double Digits With Two AI Companies

China Digest: VectorBuilder nears unicorn valuation; Xiaomi backs INGIN's latest round

An online platform for designing and constructing custom vectors, including plasmids, lentivirus, AAV, and other viral vectors.

Services for packaging various viral vectors such as lentivirus, AAV, adenovirus, and more, ensuring high titer and purity.

Creation of stable cell lines with desired genetic modifications using CRISPR and other techniques, including antibiotic selection and cell sorting.

Design and construction of custom mutagenesis libraries using various strategies like error-prone PCR, degenerate codon utilization, and DNA shuffling.

Directed evolution of AAV capsids to develop novel variants with improved properties for gene therapy and vaccine applications.

Provision of various drug-selection markers such as puromycin, neomycin, hygromycin B, and blasticidin for use in vectors.

news impact assignment basic	general
public peers	general	Nov 16, 2024 1:25 PM	521530f9
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 16, 2024 1:25 PM	0da10a0d
crunchbase trigger	general	Nov 16, 2024 1:25 PM	6b883800
crunchbase profile	general	Nov 16, 2024 1:27 PM	f5da6f80
li profile	general	Nov 16, 2024 1:25 PM	00bf1439
translate crunchbase fundingrounds	general	Nov 16, 2024 1:47 PM	1901eb4e
peers	general	Nov 16, 2024 1:25 PM	4b3efc38
news basic	general	Nov 16, 2024 1:25 PM	1568f903
bundesanzeiger	filings
financials download nd	financials
private financials	financials

VECT

COM:VECTORBUILDER:EN

VectorBuilder